Phase 2
๐ Investigational Drug / Biologic
NCT03980769
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
View Study & Screener โ